Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Clin Neurol Neurosurg ; 217: 107238, 2022 06.
Article in English | MEDLINE | ID: mdl-35429854

ABSTRACT

Brain ischemia affects the integrity of local white matter and regions that are distant to the primary lesion location. In this study, we analyzed the patterns of white matter microstructural damage and the cognitive performance of 22 patients with left hemisphere stroke. Patients were divided in two groups: one with target lesion affecting the left inferior frontal gyrus (left inferior frontal gyrus, LIFG, n = 11) and the other without ischemic lesion in this region (non-left inferior frontal gyrus, NLIFG, n = 11). Each group was compared with 11 matched healthy controls. Tract-Based Spatial Statistics was used to assess differences in diffusion tensor indices between the groups and for the association of white matter structure with cognitive performance. When compared to Controls, the LIFG showed extensive intra- and interhemispheric disconnection, with surrogate markers for tissue loss with demyelination in the corpus callosum, and microstructural changes that are independent of gross tissue loss in the contralateral hemisphere. The NLIFG group presented discrete alterations in white matter from the ipsilateral hemisphere, with surrogate markers for tissue loss with axonal injury. When LIFG is compared to NLIFG, white matter abnormalities with no gross tissue loss were observed in the corpus callosum and in the contralateral hemisphere. In addition LIFG had worse performance on cognitive functions. In conclusion, our results identify different diffusion profiles for LIFG and NLIFG groups, suggesting more extensive and pronounced white matter damage in the commissural and interhemispheric connections in the LIFG group, in addition to more pronounced cognitive impairment.


Subject(s)
Ischemic Stroke , Stroke , White Matter , Brain Damage, Chronic , Cognition , Diffusion Tensor Imaging/methods , Humans , Prefrontal Cortex , Stroke/complications , White Matter/pathology
2.
Food Chem Toxicol ; 49(11): 2934-41, 2011 Nov.
Article in English | MEDLINE | ID: mdl-21820028

ABSTRACT

Chlorella vulgaris (CV) was examined for its modulating effects on the reduction induced by lead (Pb) on the numbers of marrow hematopoietic stem cells (HSCs) (c-Kit(+)Lin(-)), granulocyte-macrophage progenitors (Gr1(+)Mac1(+)) and total bone marrow cellularity. In mice gavage-treated daily with 50mg/kg dose of CV for 10 days, concomitant to a continuous offering of 1300 ppm lead acetate in drinking water, the treatment with the algae recovered the significantly reduced numbers of these cell populations to control values. As CV may have a myelostimulating effect through the induction of cytokines, we evaluated its modulating effects on the production of IL-1α, TNF-α, IFN-γ, IL-10 and IL-6. Our results demonstrated that lead significantly impairs the production of IFN-γ, IL-1α and TNF-α and increases the production of IL-10 and IL-6 and that these effects are successfully modulated by the CV treatment. The activity of NK cells, reduced in Pb-exposed animals, was raised to levels higher than those of controls in the exposed group treated with CV. Treatment with the algae also stimulated the production of IFN-γ, IL-1α, TNF-α and NK cells activity in normal mice. In addition, zinc bone concentrations, reduced in lead-exposed mice, were partially, but significantly, reversed by the treatment with CV.


Subject(s)
Bone Marrow Cells/physiology , Chlorella vulgaris , Cytokines/metabolism , Lead/toxicity , Animals , Bone Marrow Cells/drug effects , Cell Proliferation , Cytokines/genetics , Gene Expression Regulation/drug effects , Killer Cells, Natural/drug effects , Killer Cells, Natural/physiology , Male , Mice , Mice, Inbred BALB C , Phytotherapy , Zinc
3.
Int Immunopharmacol ; 10(12): 1573-9, 2010 Dec.
Article in English | MEDLINE | ID: mdl-20951668

ABSTRACT

In this study we demonstrated that the oral administration of ß-1,3-glucan (Imunoglucan®) protects mice from a lethal dose of Listeria monocytogenes (LM) when administered prophylactically for 10 days at the doses of 150 and 300 mg/kg, with survival rates up to 40%. These doses also prevented the myelosuppression and the splenomegaly caused by a sublethal infection with LM, due to increased numbers of granulocyte-macrophage progenitors (CFU-GM) in the bone marrow. Investigation of the production of colony-stimulating factors revealed an increased colony-stimulating activity (CSA) in the serum of infected mice pre-treated with Imunoglucan®. The treatment also restored the reduced ability of stromal cells to display myeloid progenitors in long-term bone marrow cultures (LTBMC) and up-regulated IL-6 and IL-1α production by these cells in the infected mice, which was consistent with higher number of non-adherent cells. Additional studies to investigate the levels of interferon-gamma (INF-γ) in the supernatant of splenocyte cultures demonstrated a further increase in the level of this cytokine in infected-treated mice, compared to infected controls. In all cases, no differences were observed between the responses of the two optimal biologically effective doses. In contrast, no significant changes were produced by the treatment with the 50mg/kg dose. In addition, no changes were observed in normal mice treated with the three doses used. All together our results suggest that orally given Imunoglucan® indirectly modulates immune activity and probably disengages Listeria induced suppression of these responses by inducing a higher reserve of myeloid progenitors in the bone marrow in consequence of biologically active cytokine release (CSFs, IL-1α, IL-6, and INF-γ).


Subject(s)
Adjuvants, Immunologic/therapeutic use , Hematopoiesis/drug effects , Hematopoiesis/immunology , Hematopoietic Stem Cells/immunology , Listeriosis/prevention & control , beta-Glucans/therapeutic use , Adjuvants, Immunologic/administration & dosage , Administration, Oral , Animals , Bone Marrow Cells/cytology , Bone Marrow Cells/drug effects , Bone Marrow Cells/immunology , Cell Culture Techniques , Cells, Cultured , Disease Models, Animal , Dose-Response Relationship, Drug , Granulocyte-Macrophage Colony-Stimulating Factor/blood , Granulocyte-Macrophage Progenitor Cells/cytology , Granulocyte-Macrophage Progenitor Cells/drug effects , Granulocyte-Macrophage Progenitor Cells/immunology , Hematopoietic Stem Cells/cytology , Hematopoietic Stem Cells/drug effects , Interferon-gamma/immunology , Interferon-gamma/metabolism , Interleukin-1alpha/biosynthesis , Interleukin-1alpha/immunology , Interleukin-6/biosynthesis , Interleukin-6/immunology , Listeria monocytogenes/drug effects , Listeriosis/complications , Listeriosis/immunology , Listeriosis/microbiology , Male , Mice , Mice, Inbred BALB C , Splenomegaly/etiology , Splenomegaly/immunology , Splenomegaly/prevention & control , beta-Glucans/administration & dosage
4.
Immunopharmacol Immunotoxicol ; 26(3): 455-67, 2004 Aug.
Article in English | MEDLINE | ID: mdl-15518178

ABSTRACT

In this study, hematopoietic cells from mice pretreated with CVE and exposed to acute cold/restraint stress were stimulated in the presence of growth factors to form colonies, thus providing accurate information about the modulation of the green algae of the stress-induced changes in the hematopoietic response. Our results demonstrated that exposure to acute stress affected hematopoiesis. Mice exposed for a 2.5-hour time period of cold and restraint presented diminished clonal capacity for CFU-GM content per femur, which was decreased by as much as 50% compared with that in control mice, in spite of the significant increase in serum colony-stimulating activity (CSA). Treatment with 50 mg/kg CVE for 5 days, previously to the stress regimen, attenuates the effects of the stress, since comparable levels of myeloid progenitors were found in the bone marrow of both CVE/stress and control mice. Moreover, the sera from stressed mice pretreated with CVE further increased the CFU-GM formation. On the contrary, the spleen seemed to be less sensitive to acute stress in our experimental conditions. These findings are in line with our previous reports showing that the stress-induced reduction in bone marrow CFU-GM of rats exposed to electric shocks is mediated by activation of the HPA axis and by secretion of opioid agonists. No changes were observed in bone marrow, spleen and thymus total cell counts, and in relative organ weights. However, a 50% reduction in the body weight loss produced by the stress was observed in mice given the extract.


Subject(s)
Bone Marrow Cells/immunology , Chlorella vulgaris , Myelopoiesis/drug effects , Stress, Physiological/prevention & control , Animals , Bone Marrow Cells/drug effects , Cold Temperature , Colony-Forming Units Assay , Colony-Stimulating Factors/blood , Granulocyte-Macrophage Colony-Stimulating Factor/pharmacology , Male , Mice , Plant Extracts/administration & dosage , Plant Extracts/pharmacology , Recombinant Proteins , Restraint, Physical , Stress, Physiological/etiology , Stress, Physiological/physiopathology , Weight Loss/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...